News | July 13, 2022
Piramal Pharma Solutions holds opening ceremony for new API Plant at Aurora, Canada
Plant is part of the company's CAD $30 million capital investment in the site
Plant is part of the company's CAD $30 million capital investment in the site
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
Subscribe To Our Newsletter & Stay Updated
